Investor Class Action Over AstraZeneca COVID-19 Drug Dismissed With Prejudice

Mealey's (September 15, 2022, 1:29 PM EDT) -- NEW YORK — A federal judge in New York on Sept. 12 ruled that shareholders in a class action against biopharmaceutical company AstraZeneca PLC and certain of its senior officials, who...
To view the full article, register now.